SCM
KDNY

Silverarc Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Silverarc Capital Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,158
Closed -$12.8K – 108
2021
Q2 		$12.8K Buy
+14,158
New +$12.8K 5.7% 1